← Leaderboards
Abraham Schneider
University Of Maryland Baltimore
$2,695,113
Attributed
$3,471,476
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $383.8K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,471,476 · 4
By mechanism
R01$2,621,726 · 2
R21$849,750 · 2
Top collaborators
- Huakun Xu6 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Yan Shu$4,220,804
- Fengtian Xue$2,809,086
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroTissuesCellsBiguanidesFda ApprovedReportingOralPharmaceutical PreparationsResponseMetforminIn VivoSoluteInsightAntidiabetic DrugsUptakeOrganic Cation TransporterPublic Health RelevanceGene FamilyGenetic ApproachAreaMalignant NeoplasmsMediatingBiopolymersDrug Costs
Grant awards (11)
Novel tunable metformin-releasing injectable scaffolds to enhance dental pulp stem cell-based craniofacial bone regeneration$351,488
R01 · FY2025 · DE · contact PI
Novel tunable metformin-releasing injectable scaffolds to enhance dental pulp stem cell-based craniofacial bone regeneration$351,488
R01 · FY2024 · DE · contact PI
Targeting the AMPK pathway to enhance dentin repair with novel metformin-releasing dental cements$231,750
R21 · FY2023 · DE · contact PI
Targeting the AMPK pathway to enhance dentin repair with novel metformin-releasing dental cements$193,125
R21 · FY2022 · DE · contact PI
A novel metformin-nanomineral scaffold as enhancer of craniofacial bone regeneration and angiogenesis via dental pulp stem cells$231,750
R21 · FY2021 · DE · contact PI
A novel metformin-nanomineral scaffold as enhancer of craniofacial bone regeneration and angiogenesis via dental pulp stem cells$193,125
R21 · FY2020 · DE · contact PI
Role of OCT-3 on metformin action in oral carcinogenesis$383,750
R01 · FY2018 · DE · contact PI
Role of OCT-3 on metformin action in oral carcinogenesis$383,750
R01 · FY2017 · DE · contact PI
Role of OCT-3 on metformin action in oral carcinogenesis$383,750
R01 · FY2016 · DE · contact PI
Role of OCT-3 on metformin action in oral carcinogenesis$383,750
R01 · FY2015 · DE · contact PI
Role of OCT-3 on metformin action in oral carcinogenesis$383,750
R01 · FY2014 · DE · contact PI